AWM
CRBP icon

Aries Wealth Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Aries Wealth Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-513
Closed -$1.7K – 197
2022
Q4 		$1.7K Hold
513
– – ﹤0.01% 189
2022
Q3 		$2K Hold
513
– – ﹤0.01% 184
2022
Q2 		$4K Buy
+513
New +$4.96K ﹤0.01% 176
2022
Q1 		– Sell
-513
Closed -$9K – 102
2021
Q4 		$9K Sell
513
-267
-34% -$7.23K ﹤0.01% 190
2021
Q3 		$24K Hold
780
– – 0.01% 178
2021
Q2 		$43K Hold
780
– – 0.02% 183
2021
Q1 		$41K Hold
780
– – 0.02% 175
2020
Q4 		$33K Sell
780
-333
-30% -$12.4K 0.02% 163
2020
Q3 		$60K Buy
1,113
+666
+149% +$121K 0.03% 148
2020
Q2 		$112K Sell
447
-483
-52% -$97.6K 0.07% 137
2020
Q1 		$136K Hold
930
– – 0.1% 123
2019
Q4 		$160K Buy
930
+83
+10% +$12.3K 0.1% 152
2019
Q3 		$118K Sell
847
-66
-7% -$11.5K 0.08% 148
2019
Q2 		$187K Hold
913
– – 0.13% 151
2019
Q1 		$190K Buy
913
+13
+1% +$2.87K 0.14% 147
2018
Q4 		$158K Hold
900
– – 0.17% 107
2018
Q3 		$204K Hold
900
– – 0.18% 123
2018
Q2 		$136K Buy
900
+167
+23% +$30.3K 0.13% 129
2018
Q1 		$140K Buy
733
+116
+19% +$26.1K 0.14% 121
2017
Q4 		$153K Buy
+617
New +$132K 0.14% 129

Other funds holding CRBP

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Aries Wealth Management's CRBP Position: Q1 2023 in Review

Aries Wealth Management sold out of Corbus Pharmaceuticals (CRBP) in Q1 2023, closing a stake of 513 shares — an estimated $1.7K sold.

Aries Wealth Management first reported a position in CRBP in Q4 2017 and held it in 20 quarters. The position peaked at $204K in Q3 2018. 30 funds tracked by Wall St. Rank hold CRBP as of Q1 2023.

  • Aries Wealth Management reported no remaining Corbus Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Aries Wealth Management sold 513 Corbus Pharmaceuticals shares in Q1 2023, an estimated $1.7K.
  • Aries Wealth Management first reported a position in Corbus Pharmaceuticals in Q4 2017 and held it in 20 quarters.
  • Aries Wealth Management's Corbus Pharmaceuticals position peaked at $204K in Q3 2018.
  • 30 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2023.

Based on Aries Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.